AdvisorShares MSOS Daily Leveraged ETF (MSOX) Analysis: Navigating Cannabis Sector Volatility
Key Takeaways
- MSOX seeks 2x daily leveraged exposure to the AdvisorShares Pure US Cannabis ETF (MSOS), amplifying returns and risks in the U.S. cannabis space.
- Net expense ratio of 0.97%, with holdings primarily swaps on top MSOS positions like CURLF (24%), TCNNF (22%), and GTBIF (21%).
- 98% allocation to multi-state operators (MSOs), focusing on small- and micro-cap U.S. cannabis firms across cultivation, retail, and biotech.
- Designed for daily trading; compounding effects make it unsuitable for long-term holds amid high sector volatility.
- Regulatory catalysts like potential Schedule III rescheduling could unlock tax relief and capital access, but federal uncertainty persists.
- Key risks include leverage decay, counterparty exposure, and cannabis-specific regulatory, agricultural, and financing hurdles.
AdvisorShares MSOS Daily Leveraged ETF (MSOX) Overview
The AdvisorShares MSOS Daily Leveraged ETF (MSOX) is an actively managed, leveraged exchange-traded fund launched on August 23, 2022, and listed on NYSE Arca. It aims to deliver, before fees and expenses, approximately two times (2x) the daily total return of the AdvisorShares Pure US Cannabis ETF (MSOS), an affiliated fund providing targeted exposure to U.S. cannabis companies. MSOX achieves this through swap agreements on MSOS and related instruments, with collateral typically held in money market funds or cash equivalents.
MSOS, in turn, invests at least 80% of its assets in securities of U.S. companies deriving at least 50% of revenue from marijuana or hemp businesses, spanning multi-state operators, cultivators, retailers, biotech, and ancillary services. MSOX's portfolio reflects this via swaps, featuring around 10 primary positions plus derivatives. Top holdings include swaps or direct exposure to CURLF (Curaleaf Holdings, 24.29%), TCNNF (Trulieve Cannabis, 22.33%), GTBIF (Green Thumb Industries, 21.09%), GLASF (Glass House Brands, 7.38%), and VRNOF (Verano Holdings, 6.86%).
Sector allocation is heavily concentrated: 98% multi-state operators (MSOs), 1.6% agriculture, 0.5% healthcare, with 100% U.S. focus and 90%+ in small/micro-cap stocks. The net expense ratio stands at 0.97% (gross 1.42%, with waivers), though swaps embed additional indirect costs. Daily portfolio adjustments maintain leverage, but volatility in cannabis may alter rebalancing. MSOX suits sophisticated day traders, not buy-and-hold investors.
Industry and Thematic Landscape
The U.S. cannabis sector, valued as the world's largest market, centers on multi-state operators navigating fragmented state legalization for medical and recreational use. Structural drivers include expanding adult-use markets in over 20 states, rising consumer demand for wellness products, and ancillary growth in cultivation tech, biotech R&D, and retail. Regulatory catalysts dominate: a December 2025 executive order accelerated DEA review for rescheduling marijuana from Schedule I to III, potentially eliminating IRC Section 280E tax penalties—estimated at $2.3 billion in 2024—and easing banking via SAFER Banking Act progress. This could attract institutional capital, currently stifled by federal illegality, fostering M&A and efficiency gains.
Macro factors like labor shortages and reshoring bolster automation in cultivation, while risks loom: illicit market competition, price compression in mature states, hemp-derived cannabinoid restrictions, and litigation delays on rescheduling (earliest effective 2027). Capital flows remain cautious, with fintech bridging cash-heavy operations, but true reform could double investments. Geopolitical stability and state ballot initiatives further shape expansion, balancing high growth potential against compliance burdens.
Performance and Positioning Snapshot
MSOX has exhibited extreme volatility reflective of leveraged exposure to cannabis swings, with recent market cycles showing sharp rallies tied to policy optimism followed by pullbacks amid delays. In recent trading sessions, heightened sensitivity to regulatory headlines—such as rescheduling progress and tax relief prospects—amplified moves, outperforming unleveraged peers during positive news flows but magnifying drawdowns in risk-off environments. Over recent months, sector rotation into alternatives amid broader equity strength positioned MSOX as a high-beta play, connecting gains to earnings improvements at top holdings like CURLF and GTBIF, alongside macro shifts in consumer spending and inflation expectations favoring vice sectors.
Daily reset mechanics underscore its tactical role, with compounding decay evident in prolonged sideways or choppy conditions. Positioning remains tied to U.S.-specific catalysts, distinguishing it from global peers and highlighting sensitivity to federal policy timelines over general market trends.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases the platform’s top-performing AI-driven trading bots under prevailing market conditions. Tickeron provides hundreds of AI bots scanning thousands of tickers across diverse strategies, timeframes, and performance metrics like win rates and profit factors. Only the strongest current performers earn a spot in this curated section, helping investors identify tools aligned with volatility, trends, or momentum. Bots vary widely—some focus on intraday scalping, others swing trades or sector rotations—offering transparency via backtested and live results. Explore the page to discover bots potentially suited to dynamic sectors like cannabis ETFs, and consider integrating them into your strategy for enhanced decision-making.
2026 Outlook and Key Factors to Monitor
Heading into 2026, MSOX’s trajectory hinges on U.S. cannabis structural evolution amid regulatory flux. Potential Schedule III rescheduling via ongoing DEA rulemaking could repeal Section 280E, slashing effective tax rates for MSOs and freeing billions for debt reduction, expansion, and dividends—bolstering top holdings like TCNNF and VRNOF. Banking reforms, if advanced via SAFER Act, promise normalized capital access, spurring M&A consolidation among cash-strapped operators and drawing institutional inflows long deterred by compliance risks.
Macro tailwinds include sustained consumer demand in new adult-use states, efficiency gains from automation amid labor shortages, and portfolio diversification into alternatives during equity rotations. Earnings cycles for holdings will spotlight profitability post-tax relief, with interstate commerce pilots as upside catalysts. Risks persist: rescheduling litigation could delay benefits to 2027, hemp restrictions crimp adjacencies, illicit competition erodes pricing, and geopolitical tensions inflate input costs. Competitive landscape features unleveraged peers like MSOS, but MSOX’s amplification suits tactical plays. Expense drag and leverage decay warrant close monitoring, alongside policy milestones, AUM stability, and volatility regimes favoring short-term positioning. Balanced exposure demands vigilance on federal timelines and sector maturation.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
MSOX saw its Stochastic Oscillator leaves the overbought zone
The Stochastic Oscillator for MSOX moved out of overbought territory on June 11, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 35 similar instances where the indicator exited the overbought zone. In of the 35 cases the stock moved lower. This puts the odds of a downward move at .
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MSOX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
MSOX broke above its upper Bollinger Band on June 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on May 28, 2026. You may want to consider a long position or call options on MSOX as a result. In of 58 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for MSOX just turned positive on June 01, 2026. Looking at past instances where MSOX's MACD turned positive, the stock continued to rise in of 25 cases over the following month. The odds of a continued upward trend are .
MSOX moved above its 50-day moving average on May 26, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where MSOX advanced for three days, in of 150 cases, the price rose further within the following month. The odds of a continued upward trend are .
Industry description
Advertisement
General Information
Category Trading